EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion

David Žižek iD, Miha Mrak iD, Matevž Jan iD, Anja Zupan Mežnar iD, Maja Ivanovski iD, Tadej Žlahtič iD, Nina Kajdič iD, Bor Antolič iD, Luka Klemen, Rafael Skale iD, Jurij Avramovič Gregorič, Jernej Štublar und 2 weitere

Europace · 2024

DOI: 10.1093/europace/euae109 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Europace, 2024. Verfasst von David Žižek und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, University Medical Centre Ljubljana, Zaloška 7, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Coronary Occlusion, Primary Prevention, Catheter Ablation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Ljubljana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Primary prevention patients with ischaemic cardiomyopathy and chronic total occlusion of an infarct-related coronary artery (CTO) are at a particularly high risk of implantable cardioverter-defibrillator (ICD) therapy occurrence. The trial was designed to evaluate the efficacy of preventive CTO-related substrate ablation strategy in ischaemic cardiomyopathy patients undergoing primary prevention ICD implantation. Methods and results The PREVENTIVE VT study was a prospective, multicentre, randomized trial including ischaemic patients with ejection fraction ≤40%, no documented ventricular arrhythmias (VAs), and evidence of scar related to the coronary CTO. Patients were randomly assigned 1:1 to a preventive substrate ablation before ICD implantation or standard therapy with ICD implantation only. The primary outcome was a composite of appropriate ICD therapy or unplanned hospitalization for VAs. Secondary outcomes included the primary outcome’s components, the incidence of appropriate ICD therapies, cardiac hospitalization, electrical storm, and cardiovascular (CV) mortality. Sixty patients were included in the study. During the mean follow-up of 44.7 ± 20.7 months, the primary outcome occurred in 5 (16.7%) patients undergoing preventive substrate ablation and in 13 (43.3%) patients receiving only ICD [hazard ratio (HR): 0.33; 95% confidence interval (CI): 0.12–0.94; P = 0.037]. Patients in the preventive ablation group also had fewer appropriate ICD therapies (P = 0.039) and the electrical storms (Log-rank: P = 0.01). While preventive ablation also reduced cardiac hospitalizations (P = 0.006), it had no significant impact on CV mortality (P = 0.151).

Conclusion

Preventive ablation of the coronary CTO-related substrate in patients undergoing primary ICD implantation is associated with the reduced risk of appropriate ICD therapy or unplanned hospitalization due to VAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableCoronary OcclusionPrimary PreventionCatheter AblationMyocardial IschemiaHumansMaleFemaleMiddle AgedAgedTreatment OutcomeProspective StudiesTachycardia, VentricularCardiomyopathiesDeath, Sudden, CardiacRisk FactorsElectric CountershockMyocardial InfarctionChronic DiseaseTime Factors

Stichwörter der Autor:innen

Catheter ablationImplantable cardioverter-defibrillatorIschaemic cardiomyopathyVentricular arrhythmia

Autor:innen und Institutionen

  • Cardiology Department, University Medical Centre Ljubljana, Zaloška 7, 1000 Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • University Medical Centre Ljubljana, Cardiovascular Surgery Department, Ljubljana, Slovenia.
  • Cardiology Division, General Hospital Celje, Celje, Slovenia.
  • Cardiology Division, General Hospital Izola, Izola, Slovenia.

ORCID-Profile: David Žižek, Miha Mrak, Matevž Jan, Anja Zupan Mežnar, Maja Ivanovski, Tadej Žlahtič, Nina Kajdič, Bor Antolič, Rafael Skale, Matjaž Šinkovec

Förderung

  • University Medical Centre Ljubljana

Zitieren

APA

Žižek, D., Mrak, M., Jan, M., Zupan Mežnar, A., Ivanovski, M., Žlahtič, T., Kajdič, N., Antolič, B., Klemen, L., Skale, R., Avramovič Gregorič, J., Štublar, J., Pernat, A., & Šinkovec, M. (2024). Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion. Europace. https://doi.org/10.1093/europace/euae109

Vancouver

Žižek D, Mrak M, Jan M, Zupan Mežnar A, Ivanovski M, Žlahtič T, et al. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion. Europace. 2024. doi:10.1093/europace/euae109

BibTeX
@article{iek2024,
  author = {Žižek, David and Mrak, Miha and Jan, Matevž and Zupan Mežnar, Anja and Ivanovski, Maja and Žlahtič, Tadej and Kajdič, Nina and Antolič, Bor and Klemen, Luka and Skale, Rafael and Avramovič Gregorič, Jurij and Štublar, Jernej and Pernat, Andrej and Šinkovec, Matjaž},
  title = {Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae109}
}
Kostenlos starten →